241 — Alibaba Health Information Technology Balance Sheet
0.000.00%
- HK$95.46bn
- HK$86.66bn
- CNY30.60bn
- 91
- 14
- 99
- 81
Annual balance sheet for Alibaba Health Information Technology, fiscal year end - March 31st, CNY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | Interim Report | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 11,637 | 10,548 | 10,917 | 9,553 | 8,100 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 773 | 1,074 | 579 | 1,911 | 2,073 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 14,200 | 13,566 | 14,914 | 13,512 | 12,276 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 52.3 | 165 | 68.5 | 104 | 69.7 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 17,739 | 19,202 | 20,748 | 19,705 | 21,178 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,401 | 4,822 | 5,437 | 5,025 | 4,742 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3,437 | 5,104 | 5,574 | 5,161 | 4,866 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 14,302 | 14,098 | 15,174 | 14,544 | 16,312 |
| Total Liabilities & Shareholders' Equity | 17,739 | 19,202 | 20,748 | 19,705 | 21,178 |
| Total Common Shares Outstanding |